1. Kuc, Katarzyna, Bielecki, Maksymilian, Racicka-Pawlukiewicz, Ewa, Czerwinski, Michał B, Cybulska-Klosowicz, Anita. 2020. The SLC6A3 gene polymorphism is related to the development of attentional functions but not to ADHD. In Scientific reports, 10, 6176. doi:10.1038/s41598-020-63296-x. https://pubmed.ncbi.nlm.nih.gov/32277231/
2. Vogiatzoglou, Angeliki V, Kontou, Panagiota I, Bagos, Pantelis G, Braliou, Georgia G. 2024. Genetic association of SLC6A3 (dopamine transporter) gene polymorphisms with personality disorders and substance abuse disorders: a systematic review and meta-analysis. In Psychiatric genetics, 34, 93-105. doi:10.1097/YPG.0000000000000375. https://pubmed.ncbi.nlm.nih.gov/39258346/
3. Rafikova, Ekaterina, Shadrina, Maria, Slominsky, Peter, Shibalev, Dmitry, Vasilyev, Vasiliy. 2021. SLC6A3 (DAT1) as a Novel Candidate Biomarker Gene for Suicidal Behavior. In Genes, 12, . doi:10.3390/genes12060861. https://pubmed.ncbi.nlm.nih.gov/34199792/
4. Pak, Kyoungjune, Seo, Seongho, Kim, Keunyoung, Lee, Myung Jun, Kim, In Joo. 2022. SLC6A3 gene polymorphisms are associated with striatal dopamine transporter changes after glucose loading. In Synapse (New York, N.Y.), 76, e22223. doi:10.1002/syn.22223. https://pubmed.ncbi.nlm.nih.gov/35098587/
5. van der Zwaluw, Carmen S, Engels, Rutger C M E, Buitelaar, Jan, Franke, Barbara, Scholte, Ron H J. . Polymorphisms in the dopamine transporter gene (SLC6A3/DAT1) and alcohol dependence in humans: a systematic review. In Pharmacogenomics, 10, 853-66. doi:10.2217/pgs.09.24. https://pubmed.ncbi.nlm.nih.gov/19450132/
6. Apsley, Abner T, Domico, Emma R, Verbiest, Max A, Anisimova, Maria, Vandenbergh, David J. 2023. A novel hypervariable variable number tandem repeat in the dopamine transporter gene (SLC6A3). In Life science alliance, 6, . doi:10.26508/lsa.202201677. https://pubmed.ncbi.nlm.nih.gov/36754567/
7. Bonvicini, C, Faraone, S V, Scassellati, C. 2016. Attention-deficit hyperactivity disorder in adults: A systematic review and meta-analysis of genetic, pharmacogenetic and biochemical studies. In Molecular psychiatry, 21, 872-84. doi:10.1038/mp.2016.74. https://pubmed.ncbi.nlm.nih.gov/27217152/